WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

  • WJPPS: NOVEMBER ISSUE PUBLISHED
  • NOVEMBER 2024 Issue has been successfully launched on NOVEMBER 2024.

Abstract

APPLICATION OF IMMUNOSUPPRESSANT CYCLOPHOSPHAMIDE IN THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS

*A.Tamil Selvan, S.Ramya Sree, S.R.Navya Sree, Mohammed Ehtesham Uddin, KVM Krishna, R.Suthakaran

Department of Pharmacology, Teegala Ram Reddy College of Pharmacy, Saroor nagar (M), Meerpet, Hyderabad-50097

ABSTRACT

Systemic lupus erythematosus is a systemic autoimmune disease that can affect any part of the body. It is a type III hypersensitivity reaction in which antibody immune complexes precipitate and causes a further immune response. It is treated with immunosuppressive agents mainly with cyclophosphamide, corticosteroids and other immunosuppressant. Diseases modifying anti-rheumatic drugs are used to reduce the incidence of flares, the process of the diseases and lower the need for steroid use, when flares occur, they are treated with corticosteroids. Cyclophosphamide is used for severe glomerulonephritis or other organ damaging complications. In more severe cases, medications that modulate the immune system are used to control the disease and prevent recurrence of symptoms. Numerous new immunosuppressive drugs are being actively tested for SLE.

Keywords: Systemic lupus erythematosus, cyclophosphamide, immunosuppressant, DNA, anti-DNA, cytokine recpetors.


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More